Are you evaluating a patient who has been treated with sunitinib?

Has there been a rise in serum parathyroid hormone (PTH) from baseline?

Did the serum PTH return to baseline within 2-4 months of discontinuation of sunitinib therapy?

Is urine calcium excretion decreased during sunitinib therapy?

Is there serum hypophosphatemia during therapy?

Is there another diagnosis that can explain the findings better?


Please fill out required fields.